Menu
×
×

Sign Up

Your Profile will be reviewed by Admin
TODAY : Advance Search
EVENT DATES
Jun 2016
MoTuWeThFrSaSu
  12345
6789101112
13141516171819
20212223242526
27282930   

Venue

TBD
Google Map

No Opportunity Unturned: Optimizing Orphan Drug Development

Online Event

Overview

Regulations supporting orphan drug research have been evolving for more than 20 years, providing incentives and guidance for development of potentially promising drugs to treat rare indications. More recently, with global attention and advocacy focused on improving treatments in these areas of unmet need, regulators and legislators have sought meaningful changes in the design and execution of rare disease drug development programs.

Understanding existing resources, financial aid, and incentives — and how to access them — is important for any orphan product developer. This webinar will describe support offerings available through global regulatory agencies and examine pending initiatives affecting orphan drug clinical development. These include:

    Relevant guidance documents such as natural history studies and biomarkers.
    Expedited review pathways such as FDA breakthrough therapy and EMA accelerated assessment designations.
    Engaging regulators to advance development of priority medicines.
    What lawmakers are discussing

SERVICE PROVIDERS

RELATED EVENTS +

MORE events +